Inaxaplin Clinical Trials (2026): 1 Studies for Proteinuric Kidney Disease
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 Inaxaplin clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Proteinuric Kidney Disease) and 42 total planned enrollment. Most recent activity: NCT06794996 (Dec 2026).
Inaxaplin clinical trials at a glance: phase × recruitment status
| Phase | active not recruiting | Total |
|---|---|---|
| P2 | 1 | 1 |
Inaxaplin pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| AMPLIFIED | NCT06794996 | P2 | active not recruiting | Proteinuric Kidney Disease | 42 | — |
All Inaxaplin trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06794996 | AMPLIFIED | Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities | P2 | active not recruiting | 42 | Vertex Pharmaceuticals Incorporated | Feb 2025 |
Inaxaplin clinical trials: frequently asked questions
- How many Inaxaplin clinical trials are there?
- 1 Inaxaplin clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are Inaxaplin clinical trials recruiting in 2026?
- No active Inaxaplin trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is Inaxaplin being studied for?
- Inaxaplin is being studied for Proteinuric Kidney Disease. The trials are grouped by indication on this page.
- What phase is Inaxaplin in?
- Inaxaplin clinical trials span 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Inaxaplin clinical trials?
- The lead sponsor across the most Inaxaplin trials is Vertex Pharmaceuticals Incorporated. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Inaxaplinas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: